Carbone Cancer Center / University of Wisconsin

Madison, Wisconsin

We've found

1 trials

at this facility

A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Madison, WI

Use our guide to learn which trials are right for you!